BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26298002)

  • 1. Combined effects of lactoferrin and lysozyme on Streptococcus pneumoniae killing.
    André GO; Politano WR; Mirza S; Converso TR; Ferraz LF; Leite LC; Darrieux M
    Microb Pathog; 2015 Dec; 89():7-17. PubMed ID: 26298002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of differences in pspA alleles and capsular types on the resistance of Streptococcus pneumoniae to killing by apolactoferrin.
    Mirza S; Benjamin WH; Coan PA; Hwang SA; Winslett AK; Yother J; Hollingshead SK; Fujihashi K; Briles DE
    Microb Pathog; 2016 Oct; 99():209-219. PubMed ID: 27569531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].
    Shaper M; Hollingshead SK; Benjamin WH; Briles DE
    Infect Immun; 2004 Sep; 72(9):5031-40. PubMed ID: 15321996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of binding of human lactoferrin to pneumococcal surface protein A.
    Håkansson A; Roche H; Mirza S; McDaniel LS; Brooks-Walter A; Briles DE
    Infect Immun; 2001 May; 69(5):3372-81. PubMed ID: 11292760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a modified opsonophagocytic killing assay for anti-pneumococcal surface protein A antibody.
    Kuroda E; Koizumi Y; Piao Z; Nakayama H; Tomono K; Oishi K; Hamaguchi S; Akeda Y
    J Microbiol Methods; 2023 Sep; 212():106804. PubMed ID: 37543109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PspA facilitates evasion of pneumococci from bactericidal activity of neutrophil extracellular traps (NETs).
    Martinez PJ; Farhan A; Mustafa M; Javaid N; Darkoh C; Garrido-Sanabria E; Fisher-Hoch SP; Briles DE; Kantarci A; Mirza S
    Microb Pathog; 2019 Nov; 136():103653. PubMed ID: 31398527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Lee HY; Andalibi A; Webster P; Moon SK; Teufert K; Kang SH; Li JD; Nagura M; Ganz T; Lim DJ
    BMC Infect Dis; 2004 May; 4():12. PubMed ID: 15125783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae.
    Daniels CC; Briles TC; Mirza S; Håkansson AP; Briles DE
    Microb Pathog; 2006 May; 40(5):228-33. PubMed ID: 16540281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.
    Ren B; Szalai AJ; Thomas O; Hollingshead SK; Briles DE
    Infect Immun; 2003 Jan; 71(1):75-85. PubMed ID: 12496151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism.
    Senkovich O; Cook WJ; Mirza S; Hollingshead SK; Protasevich II; Briles DE; Chattopadhyay D
    J Mol Biol; 2007 Jul; 370(4):701-13. PubMed ID: 17543335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae.
    Hammerschmidt S; Bethe G; Remane PH; Chhatwal GS
    Infect Immun; 1999 Apr; 67(4):1683-7. PubMed ID: 10085004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A.
    Afshari E; Cohan RA; Sotoodehnejadnematalahi F; Mousavi SF
    J Transl Med; 2023 Jan; 21(1):13. PubMed ID: 36627666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.
    Ochs MM; Bartlett W; Briles DE; Hicks B; Jurkuvenas A; Lau P; Ren B; Millar A
    Microb Pathog; 2008 Mar; 44(3):204-14. PubMed ID: 18006268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal effect of bovine lactoferrin and synthetic peptide lactoferrin chimera in Streptococcus pneumoniae and the decrease in luxS gene expression by lactoferrin.
    León-Sicairos N; Angulo-Zamudio UA; Vidal JE; López-Torres CA; Bolscher JG; Nazmi K; Reyes-Cortes R; Reyes-López M; de la Garza M; Canizalez-Román A
    Biometals; 2014 Oct; 27(5):969-80. PubMed ID: 25053107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA.
    Genschmer KR; Vadesilho CFM; McDaniel LS; Park SS; Hale Y; Miyaji EN; Briles DE
    mSphere; 2019 Dec; 4(6):. PubMed ID: 31826968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.
    Mukerji R; Mirza S; Roche AM; Widener RW; Croney CM; Rhee DK; Weiser JN; Szalai AJ; Briles DE
    J Immunol; 2012 Dec; 189(11):5327-35. PubMed ID: 23105137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.
    Díez-Martínez R; De Paz HD; García-Fernández E; Bustamante N; Euler CW; Fischetti VA; Menendez M; García P
    J Antimicrob Chemother; 2015; 70(6):1763-73. PubMed ID: 25733585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling molecular mechanisms of pneumococcal surface protein A interactions with antibodies and lactoferrin.
    Jedrzejas MJ
    Clin Chim Acta; 2006 May; 367(1-2):1-10. PubMed ID: 16513101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.
    Mirza S; Wilson L; Benjamin WH; Novak J; Barnes S; Hollingshead SK; Briles DE
    Infect Immun; 2011 Jun; 79(6):2440-50. PubMed ID: 21422179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.